Harvard Bioscience
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Harvard Bioscience's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 1% to $112,250,000. The net income raised on -$3,415,000 and profit margin reached -3%. Total operating expenses were $64,497,000.

Profit Margin

Harvard Bioscience, Inc. (NASDAQ:HBIO): Profit margin
2014 108.66M 2.35M 2.17%
2015 108.66M -19.03M -17.52%
2016 104.52M -4.30M -4.12%
2017 101.88M -865K -0.85%
2018 120.77M -3.46M -2.87%
2019 116.17M -4.68M -4.03%
2020 102.1M -7.81M -7.65%
2021 118.90M -288K -0.24%
2022 113.33M -9.51M -8.4%
2023 112.25M -3.41M -3.04%

HBIO Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
112.25M113.33M118.90M102.1M116.17M120.77M101.88M104.52M108.66M108.66M
Cost of revenue
46.17M52.51M51.25M44.05M51.85M57.59M54.28M56.10M59.94M59.31M
Gross profit
66.07M60.81M67.65M58.04M64.32M63.18M47.59M48.41M48.72M49.34M
Operating exp.
Research and development
11.76M12.32M10.79M8.68M10.71M10.98M5.64M5.39M6.42M4.88M
Selling and marketing
24.10M25.04M24.64M19.91M23.26M24.44M21.03M20.48M20.57M18.22M
Total operating expenses
64.49M67.98M65.58M57.82M62.48M62.19M47.69M49.55M49.64M42.50M
Operating income
1.89M-7.16M1.4M-585K1.47M984K-101K-2.99M-1.71M6.61M
Other income (expenses), net
-4.45M-2.01M-1.54M-7.51M-6.97M-4.13M-1.98M-1.30M-1.89M-2.20M
Income before tax
-2.55M-9.17M-140K-7.29M-5.50M-8.51M-2.08M-3.07M-3.60M4.41M
Income tax expense
859K337K148K518K-815K-3.67M-1.22M1.22M15.43M2.06M
Net income
-3.41M-9.51M-288K-7.81M-4.68M-3.46M-865K-4.30M-19.03M2.35M
Earnings per share
Basic EPS
-0.08-0.23-0.00-0.2-0.12-0.09-0.02-0.13-0.570.07
Diluted EPS
-0.08-0.23-0.00-0.2-0.12-0.09-0.02-0.13-0.570.07
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source